Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/18 16:05 | 4/2/18 | NVTA | Health | Health | Medical Laboratories | Scott Randal W | CA | DO | Exec CB | P | 200 | 4.50 | 0 | 44 | 1 | 3,551 | I | ||||||||||||||
3/29/18 15:59 | 3/28/18 | NVTA | Health | Health | Medical Laboratories | Baker Bros. Advisors LP | NY | T | P | 5,000 | 4.50 | 0 | 1,111 | 17 | 7,554 | I | |||||||||||||||
11/22/16 18:07 | 11/22/16 | NVTA | Health | Health | Medical Laboratories | Scott Randal W | CA | DOT | CB,CEO | P | 400 | 6.00 | 4 | 67 | 2 | 3,506 | D | -2 | -26 | -22 | -12 | -8 | -26 | -2 | 6 | 0 | 5 | 47 | |||
11/21/16 19:14 | 11/18/16 | NVTA | Health | Health | Medical Laboratories | Crouse Geoffrey | CA | D | P | 94 | 6.25 | 3 | 15 | 78 | 34 | D | -10 | -29 | -29 | -25 | -21 | -28 | -29 | 2 | 6 | 11 | 55 | ||||
11/21/16 18:29 | 11/18/16 | NVTA | Health | Health | Medical Laboratories | Aguiar Eric | CA | D | P | 63 | 6.28 | 3 | 10 | New | 10 | D | -10 | -29 | -29 | -25 | -21 | -28 | -29 | 2 | 6 | 11 | 55 | ||||
11/18/16 16:36 | 11/17/16 | NVTA | Health | Health | Medical Laboratories | Baker Bros. Advisors LP | NY | T | P | 4,400 | 6.00 | 3 | 733 | 13 | 6,554 | I | -11 | -26 | -29 | -28 | -18 | -23 | -30 | 13 | 21 | 19 | 69 | ||||
2/12/16 17:00 | 2/11/16 | NVTA | Health | Health | Medical Laboratories | George Sean E | CA | DO | P,COO | P | 104 | 6.16 | 1 | 17 | 8 | 235 | D | -27 | -9 | -21 | -18 | -7 | -7 | 3 | 16 | 34 | 37 | 39 | 39 | ||
8/13/15 16:30 | 8/11/15 | NVTA | Health | Health | Medical Laboratories | George Sean E | CA | DO | P,COO | P.m | 458 | 9.18 | 2 | 50 | 30 | 218 | D | -28 | -40 | -20 | -9 | -11 | -2 | 0 | 25 | -18 | -25 | 1 | |||
2/19/15 19:13 | 2/18/15 | NVTA | Health | Health | Medical Laboratories | Flynn James E | NY | TH | Possible | P.d | 2,800 | 16.00 | 33 | 175 | 105 | 342 | I | 27 | 2 | -6 | -7 | -23 | -53 | -59 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |